ArticleOncoTargets and therapy2024

CRISPR-Cas13a Targeting the FGFR3-TACC3 Fusion Gene Inhibits Proliferation of Bladder Cancer Cells in vitro and in vivo.

Yadong Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.